CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate With Poor Prognosis
Cancer Research - United States
doi 10.1158/0008-5472.can-14-2788
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2015
Authors
Publisher
American Association for Cancer Research (AACR)